Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.

October 7, 2019 2437 Views
Merck announced September 17th that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application ...
March 4, 2019 3762 Views
Merck & Co has announced that it is making moves to acquire late-stage immunotherapy company, Immune Design for ...
December 14, 2018 5560 Views
The FDA has granted breakthrough device designation to an artificial intelligence software that is being developed by Bayer ...
banner